Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mike Klein
AddedMar 31, 2024
UpdatedMay 31, 2026
Mike Klein

Mike Klein

Board Member, Icad

CrunchbaseLinkedIn

Mike Klein's Career

Icad
Icad

Nashua, NH, US

Board Member· Board
Avenda Health
Avenda Health

Santa Monica, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mike Klein's Career

Icad
Icad
Public$59.5M1091984Nashua, NH, US
Board Member· Board

Leadership at Icad

Susan WoodSusan WoodBoard Member
Rakesh PatelRakesh PatelBoard Member
Thomas RuschThomas RuschFounder
Dana BrownDana BrownBoard Member
Andrew SassineAndrew SassineBoard Member
Elliot SussmanElliot SussmanBoard Member
Avenda Health
Avenda Health
Series B$19.3M292017Santa Monica, CA, US
Board Member· Board

Leadership at Avenda Health

Shyam NatarajanShyam NatarajanCo-Founder
Leonard MarksLeonard MarksCo-Founder
Brittany Berry-PuseyBrittany Berry-PuseyCo-Founder

Similar to Avenda Health

Avana HealthAvana HealthLexington, KY, USMedical Devices, Treatmentsest. 2021Avana HealthLexington, KY, US · est. 2021

Avana Health: Innovating women's health with uterine treatment platforms and drug-device systems.

Seed · $610k5
UndahealthUndahealthNew York City, NY, USChronic Disease, Telehealthest. 2021UndahealthNew York City, NY, US · est. 2021

AI-powered telehealth platform for managing and preventing chronic diseases.

Pre-Seed · $150k6
Advantia HealthAdvantia HealthArlington, VA, USHealthcare, Womens Healthest. 2014Advantia HealthArlington, VA, US · est. 2014

Advantia Health: An integrated online platform for comprehensive women's healthcare in the US.

Series D · $149.5M750
ApervitaApervitaChicago, IL, USHealthcare, Softwareest. 2012ApervitaChicago, IL, US · est. 2012

Apervita, a healthcare innovation company, is transforming quality measurement and care delivery to improve patient outcomes and reduce costs.

Series B · $59.5M75

Mike Klein's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Mike Klein

Gilad GlickGilad GlickBoard Member · Beta BionicsPat ShraderPat ShraderBoard Member · NDI MedicalPatrick HeimPatrick HeimBoard Member · PreemptDavid MichaelDavid MichaelBoard Member · Pivotal SystemsRichard KurtzRichard KurtzBoard Member · EvoNexusChris RamsborgChris RamsborgBoard Member · Inceptor Bio